Document Classification

Section Type: RESULTS

Text: At 4-6 wk after the end of therapy, H. pylori was eradicated from 94 % (44 of 47) of patients receiving lansoprazole, clarithromycin, and amoxicillin triple therapy, 77 % (39 of 51) of those receiving lansoprazole t. i. d. / amoxicillin t. i. d., 75 % (36 of 48) of those receiving lansoprazole b. i. d. / clarithromycin t. i. d., 57 % (28 of 49) of those receiving lansoprazole b. i. d. / clarithromycin b. i. d., 53 % (26 of 49) of those receiving lansoprazole b. i. d. / amoxicillin t. i. d., and 2 % (1 of 53) of those receiving lansoprazole monotherapy (p < or = 0. 05, triple therapy vs each dual therapy and each dual therapy vs monotherapy).